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Abstract
Background Preference-based health index scores pro-
vide a single summary score assessing overall health-
related quality of life and are useful as an outcome measure
in clinical studies, for estimating quality-adjusted life years
for economic evaluations, and for monitoring the health of
populations. We predicted EuroQoL (EQ-5D) index scores
from patient-reported outcomes measurement information
system (PROMIS) global items and domain item banks.
Methods This was a secondary analysis of health out-
come data collected in an internet survey as part of the
PROMIS Wave 1 ﬁeld testing. For this study, we included
the 10 global items and the physical function, fatigue, pain
impact, anxiety, and depression item banks. Linear
regression analyses were used to predict EQ-5D index
scores based on the global items and selected domain
banks.
Results The regression models using eight of the PRO-
MIS global items (quality of life, physical activities, mental
health, emotional problems, social activities, pain, and
fatigue and either general health or physical health items)
explained 65% of the variance in the EQ-5D. When the
PROMIS domain scores were included in a regression
model, 57% of the variance was explained in EQ-5D
scores. Comparisons of predicted to actual EQ-5D scores
by age and gender groups showed that they were similar.
Conclusions EQ-5D preference scores can be predicted
accurately from either the PROMIS global items or selec-
ted domain banks. Application of the derived regression
model allows the estimation of health preference scores
from the PROMIS health measures for use in economic
evaluations.
Keywords Health preference scores  EQ-5D 
PROMIS  Global health status 
Health-related quality of life
Introduction
Health outcomes assessment has advanced to a point where
generic health-related quality of life (HRQL) measures are
often used to examine the health status of populations and
the effects of medical interventions. Generic HRQL proﬁle
measures, such as the SF-36 Health Survey [1], provide
multiple health domains scores (e.g., physical function,
mental health, pain, vitality, etc.), but not an overall index
score. Preference-based health index scores provide a sin-
gle summary score assessing overall health-related quality
of life and are useful as an outcome measure in clinical
studies, for estimating quality-adjusted life years for eco-
nomic evaluations, and for monitoring the health of pop-
ulations. Preference-based HRQL instruments provide
information on the value of different health states and can
be used to estimate health outcomes for cost-effectiveness
analyses [2, 3].
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which includes the EuroQoL EQ-5D [4], the health utilities
index (HUI) [5, 6], and the Quality of Well-Being Scale–
Self Administered [7]. In addition, a preference-based
score, the SF-6D, has been estimated from SF-36 items [8,
9]. Although each of these health indexes provides valua-
tions on a 0 (dead) to 1 (perfect health) scale, they differ in
health state classiﬁcation systems, methods for preference
assessment, and scoring algorithms. US normative data for
these measures have been developed based on the National
Health Measurement Study [2] and other national surveys
[10, 11].
Previous studies have derived preference-based scores
from generic HRQL proﬁle measures [8, 9, 12, 13]. Law-
rence and Fleishman [14] and Sullivan and Ghushchyan
[15] discussed mapping the EQ-5D index from the SF-12
using nationally representative samples. Gray et al. [16]
used regression analysis to explore the association between
responses to the SF-12 and responses to each EQ-5D
question, and found that both the US-based data (from the
2000 Medical Expenditure Panel Survey [MEPS]) and the
UK-based data (from the 1996 Health Survey for England
[HSE]) had similar demographic characteristics, as well as
physical component summary (PCS) and mental compo-
nent summary (MCS) scores, though HSE had higher mean
EQ-5D index scores. Comparisons of EQ-5D index scores
derived from the US and UK algorithms found that the US
model predicted higher scores than the UK model for
almost all EQ-5D health states, while the US model
resulted in smaller gains in health preferences than the UK
model for the large majority of simulated transitions
between EQ-5D health states [17]. Mapping of the SF-12 to
the EQ-5D index in a nationally representative US sample
has also been conducted, though this was completed
without the use of US population weights [18]. The use of
mapping estimation methods allows patient preference
scores to be derived from health status proﬁles based on the
empirical relationship between these constructs, which is
particularly useful when patient preference scores are
unavailable.
Recently, the patient-reported outcomes measurement
information system (PROMIS) project has developed sev-
eral health domain item banks [19] and a short-form ver-
sion of a global health questionnaire, a new generic health
status measure based on the review of PROMIS item banks
(Hays et al., submitted). Given that the PROMIS domain
scores and global items are likely to see increased appli-
cation in National Institutes of Health (NIH) and other
studies, estimating health preference scores from the
PROMIS measures will be useful for those studies where
assessments of health preferences have not been included.
These estimated health preference scores will be useful for
economic analyses using data from studies that include the
PROMIS domain and global short-form instruments. The
objective of this study was to estimate health preference
scores based on the EQ-5D index, using selected PROMIS
domain scores and the summary scores from the PROMIS
global short form. We also compared the estimated health
preference scores to EQ-5D index scores from several US
national surveys by age and gender groups [2, 10].
Methods
Study design
The PROMIS item banks were administered via web-based
survey to a national internet panel maintained by Polime-
trix (now YouGovPolimetrix; see http://www.polimetrix.
com). The ﬁeld test involved administering the item banks
from ﬁve domains (i.e., pain, fatigue, physical functioning,
social activities, emotional distress) to selected participants
[19]. Some respondents were randomly assigned to
administer different complete item banks, that is, all the
items within a deﬁned domain-speciﬁc bank, such as
physical function or fatigue. Other respondents were ran-
domly assigned to block-form item samples consisting of
sets of seven consecutive items from each of 14 subdo-
mains in the ﬁve PROMIS health domains.
Study participants
The PROMIS sample was selected to be generally compa-
rable to distributions of gender, age groups, race/ethnicity
(white/African–American/Hispanic/other), and education
(high school or less versus more than high school) based on
the 2000 US census data (Liu et al., submitted). Study par-
ticipants were identiﬁed from the Polimetrix internet panel
and from selected clinical research centers. For the current
study, the participants included subjects who administered
the full item banks and the block data.
Wave 1 sample
BecauseofthenumberofitembanksbeingtestedinWave1,
a complex data-collection strategy was employed. This
strategyincludedtwoarmsandatotalsamplesizeof21,133.
Atotalof19,601subjectswere recruited byPolimetrix,with
the remaining 1,532 subjects recruited by PROMIS research
sites (Fig. 1). In the full-bank testing arm, 7,005 persons
fromthegeneralpopulationwereadministeredtwoofthe14,
56-item, subdomain-speciﬁc PROMIS item banks. In the
block testing arm, 14,128 individuals administered ran-
domly selected seven-item blocks measuring each of the 14
PROMIS-targeted subdomains. The PROMIS research sites
and the Polimetrix sample included both community and
784 Qual Life Res (2009) 18:783–791
123clinical samples. Theclinicalsamplesincludedpersonswith
heart disease (n = 1,156), cancer (n = 1,754), rheumatoid
arthritis (n = 557), osteoarthritis (n = 918), psychiatric
disorders (n = 1,193), COPD (n = 1,214), spinal cord
injury (n = 531), and other conditions (n = 560).
Measures
EQ-5D
The EQ-5D is a preference-based instrument designed to
measure generic health status across ﬁve dimensions of
health: mobility, self-care, usual activities, pain/discom-
fort, and anxiety/depression, with three response levels (no
problems, some problems, extreme problems) [4]. A
unique EQ-5D health state is deﬁned by combining one
level from each of the ﬁve dimensions, and scores range
from -0.109 to 1.0, with greater scores indicating better
overall health. The calculation of the EQ-5D index scores
was based on the valuation reported by Shaw et al. [13] that
was derived from a large-scale survey of the US general
population [10]. The EQ-5D also includes a single visual
analogue scale (EQ-5D VAS) that was not used in this
study.
PROMIS global items
The PROMIS survey included ten global health items
(Hays et al. submitted). One item was the general health
question rating overall health on a poor-to-excellent scale.
The remaining items covered quality of life, mental health,
physical health (two items), pain, fatigue, social function
(two items), and emotional distress. Based on these global
items, Hays et al. (submitted) found evidence supporting
two summary scores assessing physical and mental health.
Mental health and physical health summary scores were
developed from global items in factor and item response
theory analyses conducted in the PROMIS Wave 1 sample.
The PROMIS global items were administered to all
participants in the Wave 1 sample (Fig. 1). The sum-
mary scores were calculated as sums of the relevant indi-
vidual global items, and individual global item scores
(untransformed) were included in the subsequent regres-
sion analyses.
Domain item banks
The PROMIS initial item banks were developed based on
the published literature, clinician review, and qualitative
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Fig. 1 PROMIS wave 1 sample
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123research on patients with various health conditions (for
more information, go to http://www.nihpromis.org).
Existing domain-speciﬁc instruments were also reviewed
for item content, and new items were developed for the
PROMIS item banks [19, 20]. Content of the ﬁnal set of
physical function, fatigue, pain impact, anxiety, and
depression items was revised based on the results of
cognitive debrieﬁng interviews [20]. For this study, we
used the calibrated and available item banks measuring
physical function, fatigue, pain impact, anxiety, and
depression (www.nihpromis.org). The physical function
item bank covered self-reported capability for upper
extremity and lower extremity function. The fatigue bank
was developed to cover both fatigue experience and
impact. The pain impact domain included items on vari-
ous impacts of pain on daily activities and function. The
anxiety bank included various symptoms associated with
anxiety, and the depression bank included items on
depressed mood. Each item used a ﬁve- to six-level cat-
egorical response scale. The domain scores included in
this analysis are T-scores derived from Theta scores from
the item response theory calibrations. For the physical
function domain scores, higher scores indicate better
physical functioning. For the fatigue, pain impact, anxi-
ety, and depression domain scores, higher scores indicate
more severe impairment.
Other measures
Information on demographic characteristics was collected
for the study participants (i.e., age, gender, race/ethnicity,
education). Information was also collected on a number of
chronic medical conditions in the Wave 1 sample. These
chronic conditions were classiﬁed into groups of physical
and mental health disorders.
Statistical analysis
A series of ordinary least squares (OLS) regression
models were speciﬁed where EQ-5D index scores were
predicted from different sets of PROMIS scores. First,
three sets of regression models were performed using (1)
all ten global items; (2) a subset of eight global items
(reduced because of multicollinearity); and (3) a subset of
eight global items (using alternative duplicative items).
The Wave 1 analysis sample of 20,400 cases was sepa-
rated into two randomly assigned split-half samples; the
models were developed in the ﬁrst sample and the anal-
yses replicated in the second sample to conﬁrm results.
Second, we speciﬁed an OLS regression model using the
PROMIS global item–based mental health and physical
health summary scores to predict EQ-5D index scores in
the block testing sample (n = 14,128). Finally, a
regression analysis was performed including the T-scores
for the PROMIS domain item banks for physical function,
fatigue, pain impact, anxiety, and depression using the
block design data. We selected these ﬁve domain banks
because they (1) covered important patient-reported out-
come constructs, including mental health and physical
health; and (2) these item banks were calibrated and
tested within the PROMIS project. Subjects were included
in this analysis if they completed at least three items for
each of the ﬁve relevant PROMIS domains and had an
EQ-5D index score (n = 1,658). The domain scores
included in this analysis are T-scores derived from Theta
scores from the item response theory calibrations.
We examined plots of residuals from the regression
analyses and performed a Bland-Altman assessment of
agreement [21] comparing the actual and predicted EQ-5D
index scores. A range of agreement was deﬁned as mean
bias ± 2 standard deviation (SD) units. Intraclass correla-
tion coefﬁcients (ICCs) were calculated comparing actual
and predicted EQ-5D scores.
Estimated EQ-5D index scores were also compared
with actual EQ-5D scores based on the PROMIS general
population sample by gender and age groups and by type
of chronic medical condition (n = 2,722; Liu et al. sub-
mitted). In addition, we compared the PROMIS estimated
EQ-5D index scores to those reported in the Luo et al.
[10] and Fryback et al. [2] studies by gender and age
groups.
Results
Sample demographic characteristics
The PROMIS Wave 1 analysis sample consisted of 20,400
cases. A total of 733 cases were excluded; subjects with an
average response time of less than 1 s per item (n = 573)
and/or ten consecutive items with response time less than
half a second (n = 192) were excluded from the analyses.
The overall sample (n = 20,400) was 52% female. The
sample mean age was *53 years: 12% were 18–29 years;
12% were 30–39 years; 16% were 40–49 years; 32% were
50–64 years; and 28% were 65 years or older. The racial/
ethnic breakdown was 80% white, 9% African–American,
9% Hispanic or Latino, and 2% other races (Asian/Paciﬁc
Islanders or Native Americans). Educational attainment
ranged from less than high school (3%) to college or above
(44%), with 39% reporting some college and 16% a high
school diploma. The general population sample used in
some analyses is a subset of the PROMIS Wave 1 sample.
Sample characteristics have been found to be consistent
with those of the 2000 US census data (Liu et al.,
submitted).
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123Regression analyses
To predict EQ-5D index scores, three regression models
were run using the PROMIS data. Model 1 included the 10
global items as predictors of the EQ-5D index score and
had an adjusted R-square of 0.65 (Table 1). Possible mul-
ticollinearity among the ten global items was examined
using collinearity diagnostics (tolerance, variance inﬂation,
condition index, and proportion of variance). Some multi-
collinearity was detected, particularly among the general
health and physical health items. These items were highly
correlated (r = 0.90) and had low tolerance and high var-
iance inﬂation factors. In Model 1, general health was a
signiﬁcant indicator (P = 0.0014), but physical health was
not signiﬁcant (P = 0.526). The social satisfaction item
was not signiﬁcant in Model 1 (P = 0.316), and was
dropped from subsequent regression models.
Two additional models were run to assess the effect of
including general health and physical health in separate
models (Table 1). Model 2 included the general health item,
and Model 3 included the physical health item. All global
items included in Models 2 and 3 were signiﬁcant predictors
of EQ-5D index scores, and overall model statistics for both
indicated good ﬁt. General health (P\0.0001) was a sig-
niﬁcant predictor in the absence of physical health (Model
2),while physical health (P = 0.0051)was signiﬁcant when
general health was not included (Model 3). All models
accounted for *65% of variability in EQ-5D index scores.
The three models were repeated using the second split-half
sample of Wave 1 data (R-square = 0.65). Results using the
two separate samples were very similar, and there were no
substantive differences.
The ICCs for each of the three models were 0.77.
Review of residuals suggested reasonably good ﬁt for all
three models. For example, in Model 2 the mean residual
was 0.0 (SE = 0.002), with 95% range limits of -0.17 and
0.14 based on the distribution of residuals. The other two
models had similar results. The Bland–Altman analyses
indicated that the 95% limits of agreement between the
predicted and actual EQ-5D scores ranged from -0.20 to
0.20. The largest differences were observed at the upper
extremes of EQ-5D scores ([0.90), and there was some
evidence of overestimation in the lower range (\0.30).
A regression model including only the mental health and
physical health summary scores based on the ten global
items accounted for 57% of the variance in EQ-5D index
scores. The unstandardized regression coefﬁcients for both
the mental health summary (b = 0.031, P\0.0001) and
physical health summary (b = 0.137, P\0.0001) scores
were signiﬁcant in this model.
The regression model including PROMIS physical
function, fatigue, pain impact, anxiety, and depression
scores resulted in an adjusted R-square of 0.57. Domains
were scored such that higher scores corresponded to higher
levels of the attribute (e.g., better physical function, more
fatigue). Results were in the expected directions for each
domain. Regression coefﬁcients for physical function
(b = 0.0077, P\0.0001), fatigue (b =- 0.0021, P\
0.0001), pain impact (b =- 0.0040, P\0.0001), anxiety
(b =- 0.0023, P\0.0001), and depression (b =- 0.0022,
P\0.0001) were all statistically signiﬁcant in the model.
The ICC for the PROMIS domain model was 0.73.
Review of residuals suggested reasonably good ﬁt for this
model. The mean residual was 0.0 (SE = 0.003), with 95%
range limits of -0.20 and 0.15 based on the distribution of
residuals. The Bland–Altman analysis indicated that the
95% limits of agreement between the predicted and actual
EQ-5D scores ranged from -0.21 to 0.21. The largest
differences were observed at lower EQ-5D scores (\0.40).
Comparison of predicted and actual EQ-5D index
scores
In the PROMIS general population sample, there were few
differences indentiﬁed between actual and predicted EQ-
5D index scores (Table 2). For the total sample, the actual
mean EQ-5D score was 0.85 (SD = 0.16), compared with
a predicted score of 0.85 (SD = 0.13). Differences in mean
EQ-5D index scores by age and gender groups ranged from
0 to 0.02 points, with most (87%) deviations B 0.01 points.
EQ-5D index scores by medical conditions
Table 3 summarizes actual and predicted EQ-5D index
scores by chronic conditions. As expected, subjects with
both mental and physical conditions had the lowest EQ-5D
preference scores (0.72–0.75). Subjects with no chronic
conditions reported the best EQ-5D scores (0.92–0.94).
Those with only physical or mental conditions had pref-
erence scores situated between subjects with none or both
types of chronic conditions.
Comparison of PROMIS-predicted and reported EQ-5D
index scores from other studies
We compared predicted EQ-5D index scores from the
PROMIS general population sample to gender and age
groups reported in the Luo et al. [10] study (Table 4). In
general, the preference scores were similar, although
PROMIS sample females reported somewhat lower index
scores and those aged 65 years and older reported higher
index scores when compared with the gender and age
groups in Luo et al. [10] study.
The PROMIS-predicted EQ-5D index scores were also
compared with the National Health Measurement Study
[NHMS] EQ-5D data reported by Fryback et al. [2]
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123(Table 5). Generally, the index scores were comparable for
males (differences of 0.01 to 0.02 points) but varied more
for females (differences of 0.01 to 0.08 points). The largest
differences between the PROMIS and NHMS samples
were for women aged 35–44 years (0.05 points) and
45–54 years (0.08 points). The preference scores for the
older men and women were more comparable between the
two samples.
Discussion
We estimated EQ-5D index scores using the PROMIS
global items and selected domain scores. Using different
sets of the global items, we were able to account for 65% of
the variance in preference scores. By comparison, about
57% of the variance in EQ-5D index scores was explained
by the global item summary scores or selected PROMIS
domain scores. These results are consistent with previous
research in predicting health preference scores from HRQL
proﬁle measures [8, 14, 15, 18, 22]. For example, Law-
rence and Fleishman [14] were able to explain 61–63% of
the variance in EQ-5D index scores using SF-12 summary
scores. Other researchers explained 58–63% of EQ-5D
index scores using different HRQL measures [15, 18]. The
availability of preference-based scores based on the PRO-
MIS global items and domain scores enables potential
application of these measures to population-based studies
and economic evaluations. The main advantage of the
PROMIS measures over other static health status measures
is that the PROMIS domain item banks and scores allow
ﬂexibility in administration using either targeted short
forms or computerized adaptive testing.
The estimated EQ-5D index scores based on PROMIS
global items were comparable to those directly assessed
using the EQ-5D in this sample. Based on the Bland-Alt-
man and other analyses, there was evidence of some
overestimation for EQ-5D scores under 0.40; however, the
ICCs indicated good agreement (0.77). Differences
between the predicted and actual index scores were
between 0 and 0.02 points by gender and age groups. Most
of the observed deviations were less than 0.01 points.
These ﬁndings are encouraging and suggest that the pre-
dicted EQ-5D index scores may be applied to future
studies. More importantly, the predicted EQ-5D index
scores varied by presence of physical or mental conditions
and were most impaired in those with both mental and
physical conditions. The predicted EQ-5D scores based on
the PROMIS domains were also comparable to the actual
measured EQ-5D scores, and demonstrated similar levels
of agreement to the PROMIS global items.
Table 3 Mean actual and
predicted EQ-5D index scores
by disease classiﬁcation in
PROMIS general population
Sample (n = 2,722)
Disease classiﬁcation N Actual EQ-5D
mean (SE)
Predicted EQ-5D
mean (SE)
No physical/mental conditions 778 0.94 (0.004) 0.92 (0.005)
Physical conditions only 1,234 0.85 (0.004) 0.86 (0.005)
Mental conditions only 122 0.85 (0.013) 0.84 (0.006)
Physical and mental conditions 588 0.72 (0.008) 0.75 (0.006)
Table 4 Comparing predicted PROMIS preference scores to Luo
et al. [10]
Total sample PROMIS
Mean (SE)
Luo study
Mean (SE)
0.85 (0.01) 0.87 (0.01)
Gender
Male 0.87 (0.01) 0.88 (0.01)
Female 0.83 (0.01) 0.86 (0.01)
Age groups
18–44 0.86 (0.01) 0.91 (\0.01)
45–64 0.83 (0.01) 0.84 (0.01)
65? 0.86 (0.01) 0.81 (0.01)
Table 5 Comparing predicted PROMIS preference scores to Fryback
et al. [2]
Age
groups
Males Females Total
Fryback PROMIS Fryback PROMIS Fryback PROMIS
\35 NA 0.89 NA 0.86 NA 0.87
35–44 0.89 0.87 0.89 0.84 0.89 0.85
45–54 0.88 0.86 0.87 0.79 0.87 0.82
55–64 0.86 0.85 0.84 0.82 0.85 0.83
65–74 0.87 0.88 0.84 0.85 0.86 0.86
NA not available
Table 2 Mean actual and predicted EQ-5D index scores by gender
and age groups in PROMIS general population sample (n = 2,722)
Age
groups
Males Females Total
Actual Predicted Actual Predicted Actual Predicted
\35 0.89 0.89 0.88 0.86 0.88 0.87
35–44 0.87 0.86 0.85 0.84 0.86 0.85
45–54 0.87 0.86 0.79 0.79 0.82 0.82
55–64 0.84 0.85 0.81 0.82 0.82 0.83
65–74 0.86 0.88 0.84 0.85 0.85 0.86
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123The general pattern of predicted EQ-5D index scores by
gender and age groups seen in the PROMIS sample was
comparable to those in other recent studies [2, 10]. There is
a general decline in index scores by age, although the
oldest age group (65–74 years) showed a small increase in
preference scores compared with those aged 55–64 years.
These ﬁndings are consistent with the observed EQ-5D
index scores reported in Fryback et al. [2].
There were few differences between the PROMIS
sample and the Luo et al. [10] study sample on preference
scores. However, in the PROMIS sample women reported
somewhat lower index scores, and those aged 65 years and
older reported higher index scores compared to those in
Luo et al. [10] study. The Luo et al. [10] study used self-
completion, as did the PROMIS study, and this may
explain the comparability in mean scores. We found some
differences by gender and age groups between the pre-
dicted EQ-5D index scores from the PROMIS sample and
those in the NHMS [2]. The largest differences between the
PROMIS and NHMS samples were for women aged 35–
44 years and 45–54 years. The preference scores for the
younger men and older men and women were comparable
between the two samples. These observed differences may
be due to different sampling strategies; the Fryback et al.
[2] study over-sampled the elderly and ethnic minorities,
while the PROMIS study attempted to recruit a represen-
tative national sample through an internet panel. Fryback
et al. [2] weighted to account for this oversampling, but
differences in response patterns and mode of administra-
tion (telephone interview vs. internet self-completion) may
also have contributed to observed variability. Future
research is needed to more carefully examine differences in
the PROMIS-predicted EQ-5D index scores by ethnicity,
gender, and age groups.
We recommend the PROMIS global item–based pre-
diction equation as best for estimating EQ-5D scores if
only one approach is considered. However, future appli-
cation of these prediction equations depends on the incor-
poration of either the PROMIS global items or domain
measures in future clinical and health services research
studies. Given the ﬂexibility of multi-domain short forms
and computerized adaptive testing, the PROMIS domain
item banks and domain scores may be very useful in
clinical studies. The PROMIS global items have potential
applications for large population-based and epidemiologic
studies. The existing prediction equations allow ﬂexibility
to researchers depending on the PROMIS instruments
included in their studies.
In general, if a researcher needs to include a preference-
based health outcome measure in a study, the most rec-
ommended approach is to include one of the direct (i.e.,
time trade-off, standard gamble) or indirect (i.e., EQ-5D,
HUI) measures of health preferences. As we have
demonstrated, it is possible to estimate a preference-based
score using the PROMIS global items or domain scores in
the absence of a preference-based instrument, for example,
because of respondent burden or other issues. However, the
researcher should recognize that this is a second-best
approach and that primary data collection is recommended.
There are several limitations associated with these
analyses. First, for analyses involving PROMIS global
items, the ordinal nature of these measures may impact the
coefﬁcient estimation in the regression analyses. Second,
the PROMIS data were all collected using a web-based
survey, and there may be differences between the PROMIS
sample and the US general population that may limit
generalizability of these results. However, Liu et al. (sub-
mitted) found that the PROMIS sample was comparable in
demographic characteristics and health status to samples
from the US general population.
In summary, we predicted EQ-5D index scores based on
the PROMIS global items and selected domain scores, and
these predicted preference scores varied as expected by
demographic characteristics and presence of mental or
physical conditions in the PROMIS sample. The predicted
index scores were generally comparable to other national
samples by age and gender groups. Additional research is
needed to further evaluate the validity of the predicted
index scores and should also examine other possible
approaches to mapping the PROMIS item banks, perhaps
through item response theory analysis and the resultant
theta scores or through health preference measures such as
the EQ-5D, HUI, or direct utility measures. This study
suggests that useful preference scores can be derived from
the PROMIS measures, and these predicted EQ-5D index
scores have applications in measuring the health of popu-
lations and estimating quality-adjusted life years for eco-
nomic evaluations.
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